NCT05613751View on ClinicalTrials.gov

Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children

NARecruitingINTERVENTIONAL
Enrollment

1,038

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
InfluenzaCOVID-19
Interventions
BEHAVIORAL

Nudge

Three text messages that are sent four weeks apart reminding to obtain the vaccines

Trial Locations (7)

3052

RECRUITING

The Royal Children's Hospital, Parkville

3084

RECRUITING

Mercy Hospital For Women, Heidelberg

5006

RECRUITING

Women's and Children's Hospital, Adelaide

5042

RECRUITING

Flinders Medical Centre, Bedford Park

5112

RECRUITING

Lyell McEwin Hospital, Elizabeth Vale

6008

NOT_YET_RECRUITING

King Edward Memorial Hospital, Subiaco

6009

RECRUITING

Perth Children's Hospital, Nedlands

All Listed Sponsors
lead

University of Adelaide

OTHER

NCT05613751 - Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk Children | Biotech Hunter | Biotech Hunter